forty four Furthermore, anergic cells Commonly keep the next susceptibility to apoptosis unless anti-apoptotic proteins which include BCL2 are overexpressed, as is the situation for CLL cells.forty five In fact, most big therapeutic innovations developing in the final 10 years are connected with the inhibition of BCR and BCL2-mediated signaling.gen